A Study to Test the Safety & Tolerability of Long-term UCB0107

See also
Status	Clinical Trial	Phase
Completed	`NCT04096651` - Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy	N/A
Recruiting	`NCT02194816` - Modifiable Variables in Parkinsonism (MVP)
Completed	`NCT00703677` - A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration	Phase 1/Phase 2
Completed	`NCT00382824` - Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)	N/A
Completed	`NCT04184063` - Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)	Phase 2
Recruiting	`NCT04706234` - Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies
Recruiting	`NCT04472130` - Neurodegenerative Diseases Registry
Recruiting	`NCT04139551` - Oxford Study of Quantification in Parkinsonism
Completed	`NCT02734485` - Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy	N/A
Completed	`NCT01110720` - Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy	Phase 2/Phase 3
Completed	`NCT01174771` - Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration	N/A
Completed	`NCT00465790` - Research of Biomarkers in Parkinson Disease	Phase 0
Completed	`NCT02460094` - Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy	Phase 1
Active, not recruiting	`NCT04993768` - A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)	Phase 2
Recruiting	`NCT03225144` - Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Completed	`NCT03058965` - Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain	Early Phase 1
Recruiting	`NCT02605785` - A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy	N/A
Completed	`NCT01353183` - Analysis of the Enteric Nervous System Using Colonic Biopsies	N/A
Completed	`NCT00385710` - Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)	Phase 2
Recruiting	`NCT05260151` - Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases

NCT number	NCT04658199
Study type	Interventional
Source	UCB Pharma
Contact
Status	Active, not recruiting
Phase	Phase 1
Start date	November 16, 2020
Completion date	March 30, 2027

A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms